Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05607849

Breast Cancer Screening Uptake: a Randomized Controlled Trial Assessing the Effect of a Decisional Aid

Shared Decision-making for Breast Cancer Screening in Primary Care

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20,000 (estimated)
Sponsor
Nantes University Hospital · Academic / Other
Sex
Female
Age
50 Years – 74 Years
Healthy volunteers
Not accepted

Summary

Shared decision-making for organised breast cancer screening (OBCS) could be improved by fostering interaction and exchanges of information between women and General Practitioners (GPs), for instance by including an assistance tool in the dispatch of the invitation letter for Organised Screening for breast cancer. In 2018 the national cancer Institute funded the development of a decisional aid (DA) on the theme of whether or not to take part in breast cancer screening, specific to the French setting. It is the website Discutons-mammo.fr DEDICACES project 1. DEDICACES 2 is a population-based trial with a cluster design. It studies humans, without modifying their usual care. The experiment assesses the effect of the discutons-mammo.fr tool on the decision to take part (or not) in OBCS among women who are invited for screening.

Conditions

Interventions

TypeNameDescription
OTHERThe decidons ensemble (let's decide together) leaflet and the discutons-mammo.fr (let's talk about breast cancer screening) online tool.The leaflet will include a link to access the discutons-mammo.fr DA aid tool, and will inform women about shared decision-making. The GPs of women who are sent the leaflet will also be sent a letter encouraging shared decision-making. This material will be sent 3 months after women have received their breast cancer screening invitation letter. Data related to primary and secondary objectives will be collected by questionnaire from the 2 groups. The questionnaire will be sent 2 months after participants are informed about the tool.

Timeline

Start date
2024-12-01
Primary completion
2025-06-01
Completion
2025-09-01
First posted
2022-11-07
Last updated
2024-11-15

Source: ClinicalTrials.gov record NCT05607849. Inclusion in this directory is not an endorsement.